2.50
Hdl Handle:
http://hdl.handle.net/10755/160973
Type:
Presentation
Title:
The Urogenital Atrophy Questionnaire: A self-report instrument
Abstract:
The Urogenital Atrophy Questionnaire: A self-report instrument
Conference Sponsor:Midwest Nursing Research Society
Conference Year:2010
Author:Lester, Joanne, PhD
P.I. Institution Name:The Ohio State University
Title:Nursing Administration / College of Nursing
Contact Address:1142 Holton Road, Grove City, OH, 43123, USA
Contact Telephone:614-519-8995
Co-Authors:J.L. Lester, College of Nursing, The Ohio State University, Columbus, OH; J.L. Lester, James Cancer Hospital & Solove Research Institute, The Ohio State University, Columbus, OH;
The Urogenital Atrophy Questionnaire (UAQ) is a 15-item, self-report instrument designed to measure factors related to urogenital atrophy, including symptoms related to atrophic vaginitis. Participants respond to each item using a four-point frequency scale based on a time schedule of 4 weeks. Responses are numerically weighted with an additive scoring system that allows assessment of function, satisfaction, pain, and urogenital quality of life in three domains (urologic, genital, and sexual) and ten factors: urinary incontinence, changes in urinary patterns, burning with urination, genital itching/odor, genital irritation, vaginal discharge, pain with sexual activity, interest/desire in sexual activity, partner communication, and sexual activity without genital touching. The UAQ has met baseline reliability and validity criteria. The instrument fulfills face and content validity (CVI score = 4.0). Reliability was assessed with test-retest with Pearson product moment correlation coefficient of stability (r = 0.444 to 0.926). Cronbach's standardized alpha was utilized to determine internal consistency within each of the domains as well as the whole instrument (urinary = 0.772, genital = 0.719, sexual = 0.874). Concurrent and divergent validity were established. The UAQ is the first validated instrument to measure the subjective experience of these unpleasant symptoms. Addition of the objective measure of vaginal pH provides a validated objective measure. The UAQ is a brief and concise instrument to measure the signs and symptoms of urogenital atrophy in the clinical and research settings.
Repository Posting Date:
26-Oct-2011
Date of Publication:
17-Oct-2011
Sponsors:
Midwest Nursing Research Society

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleThe Urogenital Atrophy Questionnaire: A self-report instrumenten_GB
dc.identifier.urihttp://hdl.handle.net/10755/160973-
dc.description.abstract<table><tr><td colspan="2" class="item-title">The Urogenital Atrophy Questionnaire: A self-report instrument</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Midwest Nursing Research Society</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2010</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Lester, Joanne, PhD</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">The Ohio State University</td></tr><tr class="item-author-title"><td class="label">Title:</td><td class="value">Nursing Administration / College of Nursing</td></tr><tr class="item-address"><td class="label">Contact Address:</td><td class="value">1142 Holton Road, Grove City, OH, 43123, USA</td></tr><tr class="item-phone"><td class="label">Contact Telephone:</td><td class="value">614-519-8995</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">joanne.lester@osumc.edu</td></tr><tr class="item-co-authors"><td class="label">Co-Authors:</td><td class="value">J.L. Lester, College of Nursing, The Ohio State University, Columbus, OH; J.L. Lester, James Cancer Hospital &amp; Solove Research Institute, The Ohio State University, Columbus, OH;</td></tr><tr><td colspan="2" class="item-abstract">The Urogenital Atrophy Questionnaire (UAQ) is a 15-item, self-report instrument designed to measure factors related to urogenital atrophy, including symptoms related to atrophic vaginitis. Participants respond to each item using a four-point frequency scale based on a time schedule of 4 weeks. Responses are numerically weighted with an additive scoring system that allows assessment of function, satisfaction, pain, and urogenital quality of life in three domains (urologic, genital, and sexual) and ten factors: urinary incontinence, changes in urinary patterns, burning with urination, genital itching/odor, genital irritation, vaginal discharge, pain with sexual activity, interest/desire in sexual activity, partner communication, and sexual activity without genital touching. The UAQ has met baseline reliability and validity criteria. The instrument fulfills face and content validity (CVI score = 4.0). Reliability was assessed with test-retest with Pearson product moment correlation coefficient of stability (r = 0.444 to 0.926). Cronbach's standardized alpha was utilized to determine internal consistency within each of the domains as well as the whole instrument (urinary = 0.772, genital = 0.719, sexual = 0.874). Concurrent and divergent validity were established. The UAQ is the first validated instrument to measure the subjective experience of these unpleasant symptoms. Addition of the objective measure of vaginal pH provides a validated objective measure. The UAQ is a brief and concise instrument to measure the signs and symptoms of urogenital atrophy in the clinical and research settings.</td></tr></table>en_GB
dc.date.available2011-10-26T23:13:49Z-
dc.date.issued2011-10-17en_GB
dc.date.accessioned2011-10-26T23:13:49Z-
dc.description.sponsorshipMidwest Nursing Research Societyen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.